Vanda Pharmaceuticals Inc (VNDA) — Capital Reinvestment Ratio
Vanda Pharmaceuticals Inc (VNDA) has a Capital Reinvestment Ratio of 0.00x as of March 2024, meaning it reinvests 0% of its operating cash flow ($7.57 Million) in capital expenditures ($7.00K). Check VNDA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vanda Pharmaceuticals Inc Capital Reinvestment Ratio (2009–2023)
This chart tracks Vanda Pharmaceuticals Inc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Vanda Pharmaceuticals Inc cash flow conversion.
Annual Capital Reinvestment Ratio for Vanda Pharmaceuticals Inc (2009–2023)
Year-by-year Capital Reinvestment Ratio for Vanda Pharmaceuticals Inc from 2009 to 2023. See VNDA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.03x | $12.80 Million | $383.00K | ▲ +40.9% |
| 2022 | 0.02x | $31.98 Million | $679.00K | ▲ +147.0% |
| 2021 | 0.01x | $64.21 Million | $552.00K | ▼ -75.2% |
| 2020 | 0.03x | $51.77 Million | $1.79 Million | ▲ +56.3% |
| 2019 | 0.02x | $45.95 Million | $1.02 Million | ▼ -97.4% |
| 2018 | 0.85x | $29.99 Million | $25.37 Million | ▲ +316.8% |
| 2015 | 0.20x | $12.45 Million | $2.53 Million | ▲ +186.4% |
| 2009 | 0.07x | $169.34 Million | $12.00 Million | — |